Potenzial von Escherichia coli Nissle 1917 in der Behandlung des septischen Schocks Weitere Informationen
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Weitere Informationen
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial. Weitere Informationen